Femara 2.5Mg 30 Tab

Femara 2.5 mg is a non-steroidal aromatase inhibitor containing Letrozole, designed to reduce estrogen levels in postmenopausal women. This reduction helps inhibit the growth of hormone-sensitive tumors, making it a vital treatment for breast cancer. Key Features • Contains 2.5 mg of Letrozole per tablet. • Non-steroidal aromatase inhibitor effective for hormone receptor-positive breast cancer. • Pack of 30 tablets for extended use. • Prescribed for postmenopausal women. • Helps reduce estrogen synthesis. • Used in adjuvant therapy for early-stage breast cancer.